Salbutamol-OVA

Salbutamol-OVA is a conjugate of Salbutamol and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

12352100

Biochemical Assay Reagents

Others

Inflammation/Immunology

[Salbutamol-OVA]

[1]Lu Y, et al. Chronic stress model simulated by salbutamol promotes tumorigenesis of gastric cancer cells through β2-AR/ERK/EMT pathway. J Cancer. 2022 Jan 1;13 (2) :401-412.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-NP0253/

Biochemical Assay Reagents

No Development Reported